HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A synthetic tissue kallikrein inhibitor suppresses cancer cell invasiveness.

Abstract
Serine proteinases modulate the interaction of tumor cells with extracellular matrix components during extravasation and metastasis. The serine proteinase tissue kallikrein has been previously demonstrated in several human adenocarcinomas, and we presently report the localization of immunoreactive kallikrein and its mRNA in pancreatic adenocarcinoma. In addition, a synthetic peptide-based inhibitor specific for tissue kallikrein (FE999024) was used in our studies to explore a possible role for kallikrein in cancer cell invasiveness. Matrigel invasion assays were performed with a human breast-cancer cell line, MDA-MB-231, which expresses tissue kallikrein in culture. In the presence of FE999024 invasion through Matrigel was inhibited in a dose-dependent manner to a maximum of 39%. We also developed a novel ex vivo assay in which breast cancer cells are infused into the pulmonary circulation of artificially ventilated explanted rat lungs. At intervals up to 6 hours after infusion pulmonary invasion was quantified by bronchial alveolar lavage to recover human cancer cells from the airspace. Invading cells in the lung interstitium were also quantified after immunohistochemistry with a monoclonal antibody specific for human cytokeratin 18. The synthetic kallikrein inhibitor attenuates breast cancer cell invasion into the airspace by 33% when quantified by lavage recovery and up to 34% as quantified in the lung interstitium by cytokeratin 18 immunostaining. Our results indicate tissue kallikrein may participate in the invasion and metastasis of human adenocarcinomas. The newly developed explanted rodent lung assay should be useful for the study of cancer cells, neutrophils, or other extravasating cells.
AuthorsW C Wolf, D M Evans, L Chao, J Chao
JournalThe American journal of pathology (Am J Pathol) Vol. 159 Issue 5 Pg. 1797-805 (Nov 2001) ISSN: 0002-9440 [Print] United States
PMID11696440 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Biocompatible Materials
  • Drug Combinations
  • FE 999024
  • Laminin
  • Peptides
  • Proteoglycans
  • matrigel
  • Collagen
  • Tissue Kallikreins
Topics
  • Adenocarcinoma (metabolism, pathology)
  • Animals
  • Biocompatible Materials
  • Collagen
  • Drug Combinations
  • Humans
  • Laminin
  • Lung (pathology)
  • Neoplasm Invasiveness
  • Pancreatic Neoplasms (metabolism, pathology)
  • Peptides (pharmacology)
  • Proteoglycans
  • Rats
  • Rats, Sprague-Dawley
  • Tissue Distribution
  • Tissue Kallikreins (antagonists & inhibitors, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: